Strong HLA-DR antigen expression on cancer cells relates to better prognosis of colorectal cancer patients : Possible involvement of c-myc suppression by IFN-γ in situ
Strong HLA-DR antigen expression on cancer cells relates to better prognosis of colorectal cancer patients : Possible involvement of c-myc suppression by IFN-γ in situ
批准号:
18591454
负责人:
NISHIMORI Takanori
金额:
$2.57万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2006
资助国家:
日本
项目状态:
已结题
起止时间:
2006 至 2007
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Strong HLA-DR antigen expression on cancer cells relates to better prognosis of colorectal cancer patients, although the precise mechanism is controversial. From an immunologic point of view, HLA-DR antigen, induced by IFN-γ, is required for tumor-associated antigen recognition by CD4+ T cells. For instance, as reported previously, the expression of HLA-DR antigen in normal colorectal epithelium immediately adjacent to cancer coincided significantly with the existence of IFN-γ mRNA in the tissue. From another aspect, IFN-γ has been revealed to suppress c-myc expression in vivo through stat1-dependent mechanism, which is important for cell growth, cell cycle, and chromosome instability. In this study, strong HLA-DR-positive expression on cancer cells, as expectedly, was significantly related to better prognosis of colorectal cancer patients. High IFN-γ mRNA expression in situ indicated significantly less activation of c-myc mRNA expression. Further, HLA-DR antigen expression in cancer cells, as well as Dukes stages, was an independent factor for better long-term survival by multivariate analysis. Taken together, IFN-γ, which induces HLA-DR antigens on the cell surface, also suppresses c-myc expression in situ, and is a possible non-immunologic mechanism involved in the better long-term survival of colorectal cancer patients.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
がんの早期診断に役立つ遺伝子腫瘍マーカーの開発.
开发可用于癌症早期诊断的遗传肿瘤标记物。
DOI:
--
发表时间:
2008
期刊:
影响因子:
--
作者:
[松下一之, 梶原寿子, 朝長毅, 島田英昭, 田村裕, 星野忠治, 野村文夫, 松下 一之]
通讯作者:
松下 一之
Tumor suppressor Prdx1 is a prognostic factor in Esoghageal squamous cell carcinoma patients
抑癌基因Prdx1是食管鳞状细胞癌患者的预后因素
DOI:
--
发表时间:
2007
期刊:
Oncol Rep 18(4)
影响因子:
--
作者:
[Hashino I, Nishimori T, et. al. (other 5 authors)]
通讯作者:
et. al. (other 5 authors)
c-myc遺伝子の発現制御因子を利用した癌治療・診断法の開発
使用 c-myc 基因表达调节剂开发癌症治疗和诊断方法
DOI:
--
发表时间:
2007
期刊:
影响因子:
--
作者:
[松下一之, 朝長毅, 梶原寿子, 糸賀栄, 野村文夫, 松下 一之]
通讯作者:
松下 一之
e-myc,遺伝子転写抑制因子FIR癌遺伝子治療の開発.
e-myc,基因转录抑制因子 FIR 开发癌症基因治疗。
DOI:
--
发表时间:
2007
期刊:
影响因子:
--
作者:
[松下 一之, 朝長 毅, 島田 英昭, 梶原 寿子, 間宮 後太, 松原 久裕, 山田 滋, 加野 将之, 野村 文夫]
通讯作者:
野村 文夫
千葉大学大学院医学研究院分子病態解析学
千叶大学医学研究科,分子病理学分析
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 19 条
海外基金